Page last updated: 2024-09-04

torcetrapib and Adrenal Cancer

torcetrapib has been researched along with Adrenal Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dietz, JD; Hu, X; Keiser, J; Knight, DR; Loging, WT; Perry, DA; Smith, AH; Xia, C; Yuan, H	1
Bénardeau, A; Capponi, AM; Clerc, RG; Funder, JW; Garriz, JM; Hainaut, E; Hoflack, JC; Niesor, EJ; Perez, A; Pflieger, P; Stauffer, A; Weibel, F	1

Other Studies

2 other study(ies) available for torcetrapib and Adrenal Cancer

Article	Year
Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology, 2009, Volume: 150, Issue:5 Topics: Adrenal Gland Neoplasms; Aldosterone; Anticholesteremic Agents; Blood Pressure; Calcium Signaling; Carcinoma; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Intracellular Fluid; Models, Biological; Quinolines; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship	2009
Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels. Journal of hypertension, 2010, Volume: 28, Issue:8 Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Amides; Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Cytosol; Enzyme Induction; Esters; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Gene Expression Profiling; Humans; Hypertension; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Quinolines; Rats; Rats, Inbred SHR; RNA, Small Interfering; Sodium Channels; Structure-Activity Relationship; Sulfhydryl Compounds	2010

Article

Year

Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition.

Endocrinology, 2009, Volume: 150, Issue:5

Topics: Adrenal Gland Neoplasms; Aldosterone; Anticholesteremic Agents; Blood Pressure; Calcium Signaling; Carcinoma; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Intracellular Fluid; Models, Biological; Quinolines; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship

2009

Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels.

Journal of hypertension, 2010, Volume: 28, Issue:8

Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Amides; Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Cytosol; Enzyme Induction; Esters; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Gene Expression Profiling; Humans; Hypertension; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Quinolines; Rats; Rats, Inbred SHR; RNA, Small Interfering; Sodium Channels; Structure-Activity Relationship; Sulfhydryl Compounds

2010